🇺🇸 FDA
Patent

US 6824769

Optimal compositions and methods thereof for treating HCV infections

expired A61KA61K38/212A61P

Quick answer

US patent 6824769 (Optimal compositions and methods thereof for treating HCV infections) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/212, A61P, A61P31/14